{"id":33703,"date":"2025-05-19T18:15:00","date_gmt":"2025-05-19T10:15:00","guid":{"rendered":"https:\/\/flcube.com\/?p=33703"},"modified":"2025-05-19T18:15:01","modified_gmt":"2025-05-19T10:15:01","slug":"terumo-corporation-acquires-wuxi-biologics-germany-plant-for-eur-150-million","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=33703","title":{"rendered":"Terumo Corporation Acquires WuXi Biologics’ Germany Plant for EUR 150 Million"},"content":{"rendered":"\n

Japan-based Terumo Corporation (TYO: 4543<\/a>) has entered into an agreement with China-based Contract Research, Development and Manufacturing Organization (CRDMO) WuXi Biologics (HKG: 2269<\/a>) to acquire the latter\u2019s drug product plant in Leverkusen, Germany, for EUR 150 million (USD 168 million). This strategic move aims to enhance Terumo\u2019s production capacity and global responsiveness by utilizing the newly acquired facility as its first overseas CDMO production base. This acquisition is expected to accelerate the global expansion of Terumo\u2019s CDMO business.<\/p>\n\n\n\n

Terumo\u2019s Business Scope<\/strong>
Terumo is known for developing containers such as prefilled syringes and drug delivery devices using materials suitable for pharmaceutical applications. Additionally, the company engages in the CDMO business for combination products of pharmaceuticals and medical devices, leveraging advanced manufacturing technologies.-Fineline Info & Tech<\/a><\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Japan-based Terumo Corporation (TYO: 4543) has entered into an agreement with China-based Contract Research, Development…<\/p>\n","protected":false},"author":1,"featured_media":33705,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[19,952,4081,4080,292],"class_list":["post-33703","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-cro-cmo-cdmo","tag-hkg-2269","tag-terumo","tag-tyo-4543","tag-wuxi-biologics"],"yoast_head":"\nTerumo Corporation Acquires WuXi Biologics' Germany Plant for EUR 150 Million - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Japan-based Terumo Corporation (TYO: 4543) has entered into an agreement with China-based Contract Research, Development and Manufacturing Organization (CRDMO) WuXi Biologics (HKG: 2269) to acquire the latter\u2019s drug product plant in Leverkusen, Germany, for EUR 150 million (USD 168 million). This strategic move aims to enhance Terumo\u2019s production capacity and global responsiveness by utilizing the newly acquired facility as its first overseas CDMO production base. This acquisition is expected to accelerate the global expansion of Terumo\u2019s CDMO business.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=33703\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Terumo Corporation Acquires WuXi Biologics' Germany Plant for EUR 150 Million\" \/>\n<meta property=\"og:description\" content=\"Japan-based Terumo Corporation (TYO: 4543) has entered into an agreement with China-based Contract Research, Development and Manufacturing Organization (CRDMO) WuXi Biologics (HKG: 2269) to acquire the latter\u2019s drug product plant in Leverkusen, Germany, for EUR 150 million (USD 168 million). This strategic move aims to enhance Terumo\u2019s production capacity and global responsiveness by utilizing the newly acquired facility as its first overseas CDMO production base. This acquisition is expected to accelerate the global expansion of Terumo\u2019s CDMO business.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=33703\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-19T10:15:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-19T10:15:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/1912.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33703#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33703\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Terumo Corporation Acquires WuXi Biologics’ Germany Plant for EUR 150 Million\",\"datePublished\":\"2025-05-19T10:15:00+00:00\",\"dateModified\":\"2025-05-19T10:15:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33703\"},\"wordCount\":135,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33703#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/1912.webp\",\"keywords\":[\"CRO \\\/ CMO \\\/ CDMO\",\"HKG: 2269\",\"Terumo\",\"TYO: 4543\",\"WuXi Biologics\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=33703#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33703\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=33703\",\"name\":\"Terumo Corporation Acquires WuXi Biologics' Germany Plant for EUR 150 Million - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33703#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33703#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/1912.webp\",\"datePublished\":\"2025-05-19T10:15:00+00:00\",\"dateModified\":\"2025-05-19T10:15:01+00:00\",\"description\":\"Japan-based Terumo Corporation (TYO: 4543) has entered into an agreement with China-based Contract Research, Development and Manufacturing Organization (CRDMO) WuXi Biologics (HKG: 2269) to acquire the latter\u2019s drug product plant in Leverkusen, Germany, for EUR 150 million (USD 168 million). This strategic move aims to enhance Terumo\u2019s production capacity and global responsiveness by utilizing the newly acquired facility as its first overseas CDMO production base. This acquisition is expected to accelerate the global expansion of Terumo\u2019s CDMO business.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33703#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=33703\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33703#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/1912.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/1912.webp\",\"width\":1080,\"height\":608,\"caption\":\"Terumo Corporation Acquires WuXi Biologics' Germany Plant for EUR 150 Million\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33703#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Terumo Corporation Acquires WuXi Biologics’ Germany Plant for EUR 150 Million\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Terumo Corporation Acquires WuXi Biologics' Germany Plant for EUR 150 Million - Insight, China's Pharmaceutical Industry","description":"Japan-based Terumo Corporation (TYO: 4543) has entered into an agreement with China-based Contract Research, Development and Manufacturing Organization (CRDMO) WuXi Biologics (HKG: 2269) to acquire the latter\u2019s drug product plant in Leverkusen, Germany, for EUR 150 million (USD 168 million). This strategic move aims to enhance Terumo\u2019s production capacity and global responsiveness by utilizing the newly acquired facility as its first overseas CDMO production base. This acquisition is expected to accelerate the global expansion of Terumo\u2019s CDMO business.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=33703","og_locale":"en_US","og_type":"article","og_title":"Terumo Corporation Acquires WuXi Biologics' Germany Plant for EUR 150 Million","og_description":"Japan-based Terumo Corporation (TYO: 4543) has entered into an agreement with China-based Contract Research, Development and Manufacturing Organization (CRDMO) WuXi Biologics (HKG: 2269) to acquire the latter\u2019s drug product plant in Leverkusen, Germany, for EUR 150 million (USD 168 million). This strategic move aims to enhance Terumo\u2019s production capacity and global responsiveness by utilizing the newly acquired facility as its first overseas CDMO production base. This acquisition is expected to accelerate the global expansion of Terumo\u2019s CDMO business.","og_url":"https:\/\/flcube.com\/?p=33703","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-05-19T10:15:00+00:00","article_modified_time":"2025-05-19T10:15:01+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/1912.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=33703#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=33703"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Terumo Corporation Acquires WuXi Biologics’ Germany Plant for EUR 150 Million","datePublished":"2025-05-19T10:15:00+00:00","dateModified":"2025-05-19T10:15:01+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=33703"},"wordCount":135,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=33703#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/1912.webp","keywords":["CRO \/ CMO \/ CDMO","HKG: 2269","Terumo","TYO: 4543","WuXi Biologics"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=33703#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=33703","url":"https:\/\/flcube.com\/?p=33703","name":"Terumo Corporation Acquires WuXi Biologics' Germany Plant for EUR 150 Million - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=33703#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=33703#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/1912.webp","datePublished":"2025-05-19T10:15:00+00:00","dateModified":"2025-05-19T10:15:01+00:00","description":"Japan-based Terumo Corporation (TYO: 4543) has entered into an agreement with China-based Contract Research, Development and Manufacturing Organization (CRDMO) WuXi Biologics (HKG: 2269) to acquire the latter\u2019s drug product plant in Leverkusen, Germany, for EUR 150 million (USD 168 million). This strategic move aims to enhance Terumo\u2019s production capacity and global responsiveness by utilizing the newly acquired facility as its first overseas CDMO production base. This acquisition is expected to accelerate the global expansion of Terumo\u2019s CDMO business.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=33703#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=33703"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=33703#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/1912.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/1912.webp","width":1080,"height":608,"caption":"Terumo Corporation Acquires WuXi Biologics' Germany Plant for EUR 150 Million"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=33703#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Terumo Corporation Acquires WuXi Biologics’ Germany Plant for EUR 150 Million"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/1912.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/33703","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=33703"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/33703\/revisions"}],"predecessor-version":[{"id":33706,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/33703\/revisions\/33706"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/33705"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=33703"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=33703"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=33703"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}